Bone Biologics Corp (BBLGW) Short-Term Debt issuances (2021)

Bone Biologics (BBLGW) has reported Short-Term Debt issuances for 1 consecutive years, with -$10609.0 the latest figure, recorded in Q1 2021.

• In Q1 2021, Short-Term Debt issuances changed N/A year-over-year to -$10609.0; the TTM figure through Dec 2021 stood at -$10609.0 (changed N/A YoY), while the FY2021 annual figure was -$10609.0, down 200.0% from the prior year.
• Short-Term Debt issuances steadied at -$10609.0 in Q1 2021 per BBLGW's latest filing.
• Across five years, Short-Term Debt issuances topped out at -$10609.0 in Q1 2021 and bottomed at -$10609.0 in Q1 2021.